Skip to content

Promoting Uptake and Retention of Option B+ in Malawi

Improving Uptake and Retention in PMTCT Services Through Novel Approaches in Family Supported Care and in Community Peer Outreach Support in Malawi

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02005835
Acronym
PURE
Enrollment
1050
Registered
2013-12-09
Start date
2013-11-30
Completion date
2016-08-31
Last updated
2013-12-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

HIV

Keywords

HIV, Option B+, Prevention of Mother to Child Transmission

Brief summary

The purpose of this study is to determine if enhanced support for women and their families within facilities and/or through community outreach will result in improved retention in the continuum of PMTCT care.

Detailed description

The Malawi Ministry of Health (MoH) has embarked on a novel and ambitious programme to prevent mother to child transmission of HIV (PMTCT) known as Option B Plus. This programme takes a public health approach to promote maternal health and eliminate paediatric HIV infections through a test and treat model, offering all HIV-infected pregnant and breastfeeding women lifelong ART regardless of CD4 count or clinical stage. The overall goal is to improve ART uptake and retention, and thus outcomes, of HIV-infected pregnant women and their infants in the continuum of ART services. Although the Option B Plus strategy offers an attractive rapid ART scale-up alternative to the WHO PMTCT recommendations and has the potential to profoundly impact maternal and infant outcomes, it has not been implemented in any programme setting. Operational challenges throughout the cascade of PMTCT services may affect the uptake and adherence to highly active ART treatment (HAART) by pregnant women, the follow-up of HIV-exposed infants and the long-term retention of this patient population. Several issues identified at the national level are potential threats to the successful implementation and scale up of Option B plus: a) potential suboptimal uptake of HAART by asymptomatic pregnant women due to low treatment literacy and stigma; b) low adherence to HAART and poor follow-up of HIV exposed infants; and c) lack of psycho-social support for long term retention in this relatively asymptomatic patient population (Schouten et al. 2011). The aim of the overall project (4 years) is to evaluate facility-based and community-based support models to strengthen uptake and retention of mothers and families in PMTCT care in Malawi. Our hypothesis is that enhanced support for women and their families within facilities and/or through community outreach will result in improved retention in the continuum of PMTCT care. We will conduct a cluster randomized clinical trial evaluating three support models for the implementation of the Option B+ program. Each of the 21 clinics will be randomized to one of the three adherence and support strategies. Arm 1 is the standard of care arm as outlined by the Ministry of Health, Arm 2 is facility level support by a peer educator and Arm 3 is community level support by a peer educator.

Interventions

OTHERCommunity based peer support

Community-based Support from Peer Mothers (Expert mothers): Routine standard clinical care based on the MoH guidelines Mentor mothers provide education and psychosocial support in community prior to each visit Monthly support groups in community Home visits for each missed appointment

OTHERFacility-based Peer Support

Facility-based Peer Support to provide the following at the clinic Routine standard clinical care based on the MoH guidelines Mentor mothers provide education and psychosocial support at facility Weekly support groups provided in clinic Phone call, SMS, or home visit for each missed appointment

Sponsors

World Health Organization
CollaboratorOTHER
AIDS Fonds
CollaboratorOTHER
Mothers2Mothers
CollaboratorUNKNOWN
Kamuzu University of Health Sciences
CollaboratorOTHER
Management Sciences for Health
CollaboratorOTHER
Dignitas International
CollaboratorOTHER
University of North Carolina, Chapel Hill
CollaboratorOTHER
University of Malawi
CollaboratorOTHER
Ministry of Health and Population, Malawi
CollaboratorOTHER_GOV
Lighthouse Trust
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
16 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* HIV infected women Presenting for Antenatal Care, Labor&Delivery, or post-partum Infants of Enrolled mothers Husbands/Spouses of Enrolled mothers

Exclusion criteria

\-

Design outcomes

Primary

MeasureTime frameDescription
Retention in Care12 months post ART initiationThe primary outcome is the proportion of women retained alive and on ART at 12 months post ART initiation.

Secondary

MeasureTime frameDescription
Retention at 24 months24 months post ART initiationThe proportion of Women alive and retained on ART at 24 months post ART initiation
Child HIV status6 weeks, 12 months, 24 monthsChildren tested at 6 weeks, 12 months, and 24 months
HIV free survival6 weeks, 12 months, 24 monthsHIV-free infant survival at 6-weeks, 12 months and 24 months
Family retention12 monthsPartner/family involvement, including: a) husband/children tested for HIV; b. eligible husbands/children who start ART; c. husband/children engaged in care at 12 months
Maternal resistance6 months, 2 yearsOf women failing ART, the proportion with HIV drug resistance
Infant HIV resistance6 weeks, 12 months, 24 monthsOf HIV infected infants, the proportion with HIV drug resistance
Social outcomes12, 24 monthsSocial outcomes, including impact of task shifting on burden of care in facilities, quality of life for patients and their families, disclosure and shifts in boundaries of professional and lay care for lay health care workers as assessed by mixed methodology.
Maternal Viral Load6 months and 2 years post ART initiationProportion of women with HIVRNA \<1000 copies at 6 months and 2 years post initiation

Other

MeasureTime frameDescription
Economicsbaseline, 12, 24 monthsEconomic indicators including cost effectiveness ratios of support models, equity of access to PMTCT services by geographic area, socio-economic profiles of mothers and families accessing care to assess equity, and indicators for health system impacts such as time at work, overtime, number and types of cases treated, motivation and satisfaction by health workers as assessed by mixed methodology.

Countries

Malawi

Contacts

Primary ContactClement Trapence, MSc.
c_Trapence@lighthouse.org.mw265 1 758897
Backup ContactHannock Tweya, M.P.H.
h_Tweya@lighthouse.org.mw265 1 758897

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 13, 2026